Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Lee’s Pharmaceutical Holdings Ltd Reports 32.9% Revenue Growth in 2023
March 28, 2025
Company
RemeGen’s 2024 Revenue Soars 58.54% on Strong Product Sales and R&D Growth
March 28, 2025
Company
JW Therapeutics Sees 9% Revenue Decline in 2024 Amid Commercial Strategy Shift
March 28, 2025
Company
Ascentage Pharma’s Revenue Soars 342% in 2024 on Strong Drug Sales and Partnerships
March 28, 2025
Company
Shanghai Pharmaceuticals Reports 5.75% Revenue Growth in 2024 with Innovation Initiatives
March 28, 2025
Company
Drug
YiChang HEC’s Yiqibuvir Approved by NMPA for Chronic HCV Infection
March 28, 2025
Company
Luye Pharma’s Shandong Boan Bio Reports 17.5% Revenue Growth in 2024
March 28, 2025
Company
MicroPort CardioFlow Medtech Reports 7.5% Revenue Growth in 2024 Driven by Global Expansion
March 28, 2025
Company
Drug
Hengrui Pharmaceuticals Gets NMPA Green Light for HRS-1738 and HRS-5817 Clinical Trials
March 28, 2025
Company
MicroPort MedBot Reports Strong 2024 Growth for Toumai and SkyWalker Robots
March 28, 2025
Company
Drug
Sanofi’s mRNA Chlamydia Vaccine Gains FDA Fast Track Designation
March 27, 2025
Company
Deals
Fangzhou Inc. Partners with Tencent Health to Advance AI-Driven Healthcare Solutions
March 27, 2025
1
2
…
406
407
408
409
410
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
